TRAF6 and colitis: A functional analysis revealed that ARC suppressed the ubiquitination of TRAF6 by directly interacting with it, thereby activating the NF-κB pathway in T cells and subsequently resulting in the suppression of colitis-associated carcinogenesis [67].